A Trio Of Top Biotech Stock Picks
When it comes to the future of the biotech industry, the author of today’s article notes that “the aging population ensures that demand for new… Read More »A Trio Of Top Biotech Stock Picks
Investing
With A Potential Blockbuster Drug, And Ripe For Acquisition, This Biotech Stock Could Be A Big Winner
With a potential $5+ billion drug that could ultimately be used against dozens of diseases, the clinical-stage biotech company discussed in today’s article “is a ripe acquisition target, and when that acquisition comes, it will go for a steep price.”
After Experiencing Extreme Volatility This Month, Does This Biopharma Stock Have Any Upside Left?
Shares of the relatively unknown biopharmaceutical company discussed in today’s article have experienced extreme volatility this month, hitting their all-time low on June 2nd before proceeding to soar to their all-time high on June 10th.
Biotech Gets Some Love From The FDA – And Redditors
After trailing the broader market for the past few months, biotech has gotten some love in recent days – from the FDA in the form of its approval of Biogen’s controversial Alzheimer’s drug, and also from the Reddit crowd.
Key PDUFA Dates – And Biotech Stock Catalysts – In June
As PDUFA dates can serve as catalysts for stocks, biotech investors can be well served by paying attention to them.
Decision Time In Healthcare & Biotech
What do these impending decisions mean for healthcare and biotech stocks?
Follow The Smart Money Back Into The Gene Therapy Trend With This Biotech
A year or so ago, the gene therapy trend was hot – until it quickly cooled down. But now may be the time to get back in on this trend, especially with one particular biotech stock.
What Makes This Biotech A “Strong Buy”? An Underappreciated – And Potentially Transformative – Late-Stage Pipeline
The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products.”
Why This Biotech Startup Could Be A Moderna In The Making
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.
New Stocks To Watch In Biotech, Tech, Mining & Green Energy
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the slew of new biotech stocks to watch.